Home GUDID 06950921302087 CLUNGENE
Primary DI 06950921302087
Brand CLUNGENE
Company Hangzhou Clongene Biotech Co., Ltd.
Model DDOA1c07-200308
Published 2025-07-09
Public version status Update
Distribution status In Commercial Distribution
MRI safety Labeling does not contain MRI Safety Information
Single use true Product Codes# Code, Name table Code Name NGG Test, Methamphetamine, Over The Counter NGL Test, Opiates, Over The Counter NGM Test, Phencyclidine (Pcp), Over The Counter QAW Test, Tricyclic Antidepressants, Over The Counter
Product Code Classifications# Code, Device, Specialty table Code Device Specialty Class NGG Test, Methamphetamine, Over The Counter Clinical Toxicology 2 NGL Test, Opiates, Over The Counter Clinical Toxicology 2 NGM Test, Phencyclidine (Pcp), Over The Counter Unknown U QAW Test, Tricyclic Antidepressants, Over The Counter Clinical Toxicology 2
Identifiers And Packaging# Identifier, Type, Agency table Identifier Type Agency Package quantity Status 06950921302087 Primary GS1 0
Alternate GTIN / UPC / EAN Codes Source identifier, GTIN-14 normalized, EAN-13 table Source identifier GTIN-14 normalized EAN-13 06950921302087 06950921302087 6950921302087
GMDN Terms# Term, Definition table Term Definition Multiple drugs of abuse IVD, kit, rapid ICT, clinical A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.
Regulatory Flags# DUNS number 724157438 Device count 1 Lot or batch true Manufacturing date on label true Expiration date on label true Other Devices From This Company# Other Devices Sharing Product Codes# Primary DI, Brand, Company table Primary DI Brand Company Product code Published 00850076289706 HYSEN Multiple Drugs Test Cup HYSEN INC. NGM 2026-07-20 00850076289706 HYSEN Multiple Drugs Test Cup HYSEN INC. NGL 2026-07-20 00850076289713 HYSEN Multiple Drugs Test Cup HYSEN INC. NGG 2026-07-20 00850076289713 HYSEN Multiple Drugs Test Cup HYSEN INC. NGL 2026-07-20 00850076289713 HYSEN Multiple Drugs Test Cup HYSEN INC. NGM 2026-07-20 G474M2105010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGL 2026-07-20 G474M2105010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGG 2026-07-20 G474M2107010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGG 2026-07-20 G474M2107010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGL 2026-07-20 G474M2113010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGG 2026-07-20 G474M2113010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGL 2026-07-20 G474M2116010 mLife Rapid Drug Test Mlife Diagnostics, LLC QAW 2026-07-20 G474M2116010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGM 2026-07-20 G474M2116010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGG 2026-07-20 G474M2116010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGL 2026-07-20 G474M2117010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGG 2026-07-20 G474M2117010 mLife Rapid Drug Test Mlife Diagnostics, LLC QAW 2026-07-20 G474M2117010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGM 2026-07-20 G474M2117010 mLife Rapid Drug Test Mlife Diagnostics, LLC NGL 2026-07-20 10722066018009 Rapid Response BTNX Inc QAW 2026-07-14 10722066018009 Rapid Response BTNX Inc NGM 2026-07-14 10722066018009 Rapid Response BTNX Inc NGL 2026-07-14 10722066018009 Rapid Response BTNX Inc NGG 2026-07-14 10858886006855 Noble Drug Test Cup with AD (Urine) NOBLE MEDICAL INC NGM 2026-07-09 10858886006855 Noble Drug Test Cup with AD (Urine) NOBLE MEDICAL INC NGG 2026-07-09 10858886006855 Noble Drug Test Cup with AD (Urine) NOBLE MEDICAL INC NGL 2026-07-09 00810174471229 Prime Screen® WONDFO USA CO., LTD. NGL 2026-06-26 00810174471410 Prime Screen® WONDFO USA CO., LTD. NGL 2026-06-26 00810174471410 Prime Screen® WONDFO USA CO., LTD. NGG 2026-06-26 10722066015053 Rapid Response BTNX Inc QAW 2026-05-15